Advocacy Actions

2019-01-10 > Beijing

Event on "The Development of Medical Imaging Technology in the Past 40 years"

A seminar at the Belgium Embassy on the Development of Medical Imaging Technology in the Past 40 years: How Foreign Investment in Healthcare can Support Healthy China 2030

Read more
2019-01-09 > Beijing

Seminar on IEC 60601 standards

A seminar on IEC 60601 standards, COCIR invited a speaker presented on Edtion 3 v.s. Edition 2

Read more
2019-01-09 > Shanghai

Shanghai Position Paper 2018/2019 Presented to the Shanghai Development and Reform Research Institute

Seminar on Shanghai's Advantages in Future Development in New Era by Shanghai Development and Reform Research Institute

Read more
2019-01-09 > All chapters

Meeting with Legislative Affairs Commission of the NPC Standing Committee on the Draft Foreign Investment Law

The Legislative Affairs Committee of the Standing Committee of the National People's Congress held a symposium to solicit opinions on the draft Foreign Investment Law. European Chamber representatives were invited to attend the symposium and present members’ concerns.

Read more
2019-01-07 > Beijing

Seminar on New Hospital Payment Systems

The Healthcare Equipment (HCE) Working Group hold a seminar on Diagnostic Related Groups (DRG), a new Payment System for Hospital Services.

Read more
2018-12-29 > Beijing

Comments to the CDR’s “Guideline for the Formatting of the Regular Risk Assessment Report by the Medical Devices (MAH)”

On 27 November 2018, the Centre for Drug Re-evaluation has initiated a public consultation on “Guideline for the Formatting of the Regular Risk Assessment Report by the Medical Devices (MAH)”.

Read more
2018-12-29 > Beijing

Meeting with the Center for Drug Re-evaluation for implementing Order#1 of SAMR

The Healthcare Equipment (HCE) Working Group and European Coordination Committee of the Radiological, Electromedical And Healthcare IT Industry (COCIR) visited the Center for Drugs (Medical Devices) Re-evaluation (CDR) of National Medical Products Administration (NMPA) on 29th December 2018.

Read more
2018-12-28 > Beijing

Comments to the CDR’s “Guideline for the Re-evaluation of Medical Devices”

On 27 November 2018, the Centre for Drug Re-evaluation has initiated a public consultation on “Guideline for the Re-evaluation of Medical Devices”.

Read more
2018-12-27 > Beijing

Comments to the CDR’s “Guideline for the Risk Assessment by the Medical Device Market Authorisation Holder (MAH)”

On 27 November 2018, the Centre for Drug Re-evaluation has initiated a public consultation on “Guideline for the Risk Assessment by the Medical Device Market Authorisation Holder (MAH)”.

Read more
2018-12-27 > Beijing

Comments to Ministry of Public Security (MPS) on Draft Guidelines on Internet Personal Information Security Protection

The European Chamber's ICT and Cybersecurity Working Groups submitted comments to the MPS on the draft Guidelines on Internet Personal Information Security Protection, calling for clarification on its nature and effectiveness, as well as on how it will relate to other personal information security standards already in place. The European Chamber also discourages the practice of mandating the level three classified cybersecurity protection requirements for all Internet companies/personal information holders.

Read more